Ramos H - Search Results

1

A simple linearization method unveils hidden enzymatic assay interferences.

Pinto MF, Ripoll-Rozada J, Ramos H, Watson EE, Franck C, Payne RJ, Saraiva L, Pereira PJB, Pastore A, Rocha F, Martins PM. Pinto MF, et al. Among authors: ramos h. Biophys Chem. 2019 Sep;252:106193. doi: 10.1016/j.bpc.2019.106193. Epub 2019 May 29. Biophys Chem. 2019. PMID: 31195341

2

p53 family interactions and yeast: together in anticancer therapy.

Gomes S, Leão M, Raimundo L, Ramos H, Soares J, Saraiva L. Gomes S, et al. Among authors: ramos h. Drug Discov Today. 2016 Apr;21(4):616-24. doi: 10.1016/j.drudis.2016.02.007. Epub 2016 Feb 15. Drug Discov Today. 2016. PMID: 26891980 Review.

3

p53 and glucose metabolism: an orchestra to be directed in cancer therapy.

Gomes AS, Ramos H, Soares J, Saraiva L. Gomes AS, et al. Among authors: ramos h. Pharmacol Res. 2018 May;131:75-86. doi: 10.1016/j.phrs.2018.03.015. Epub 2018 Mar 23. Pharmacol Res. 2018. PMID: 29580896 Review.

4

p73: From the p53 shadow to a major pharmacological target in anticancer therapy.

Ramos H, Raimundo L, Saraiva L. Ramos H, et al. Pharmacol Res. 2020 Dec;162:105245. doi: 10.1016/j.phrs.2020.105245. Epub 2020 Oct 15. Pharmacol Res. 2020. PMID: 33069756 Review.

5

Noncanonical roles of p53 in cancer stemness and their implications in sarcomas.

Curylova L, Ramos H, Saraiva L, Skoda J. Curylova L, et al. Among authors: ramos h. Cancer Lett. 2022 Jan 28;525:131-145. doi: 10.1016/j.canlet.2021.10.037. Epub 2021 Nov 3. Cancer Lett. 2022. PMID: 34742870 Review.

6

A Diarylpentanoid with Potential Activation of the p53 Pathway: Combination of in silico Screening Studies, Synthesis, and Biological Activity Evaluation.

Moreira J, Almeida J, Loureiro JB, Ramos H, Palmeira A, Pinto MM, Saraiva L, Cidade H. Moreira J, et al. Among authors: ramos h. ChemMedChem. 2021 Oct 6;16(19):2969-2981. doi: 10.1002/cmdc.202100337. Epub 2021 Jul 22. ChemMedChem. 2021. PMID: 34170069

7

SLMP53-1 Inhibits Tumor Cell Growth through Regulation of Glucose Metabolism and Angiogenesis in a P53-Dependent Manner.

Ramos H, Calheiros J, Almeida J, Barcherini V, Santos S, Carvalho ATP, Santos MMM, Saraiva L. Ramos H, et al. Int J Mol Sci. 2020 Jan 17;21(2):596. doi: 10.3390/ijms21020596. Int J Mol Sci. 2020. PMID: 31963392 Free PMC article.

8

BRCA1/P53: Two strengths in cancer chemoprevention.

Raimundo L, Ramos H, Loureiro JB, Calheiros J, Saraiva L. Raimundo L, et al. Among authors: ramos h. Biochim Biophys Acta Rev Cancer. 2020 Jan;1873(1):188339. doi: 10.1016/j.bbcan.2020.188339. Epub 2020 Jan 7. Biochim Biophys Acta Rev Cancer. 2020. PMID: 31917206 Review.

9

Structural and Drug Targeting Insights on Mutant p53.

Gomes AS, Ramos H, Inga A, Sousa E, Saraiva L. Gomes AS, et al. Among authors: ramos h. Cancers (Basel). 2021 Jul 3;13(13):3344. doi: 10.3390/cancers13133344. Cancers (Basel). 2021. PMID: 34283062 Free PMC article. Review.

10

DIMP53-1: a novel small-molecule dual inhibitor of p53-MDM2/X interactions with multifunctional p53-dependent anticancer properties.

Soares J, Espadinha M, Raimundo L, Ramos H, Gomes AS, Gomes S, Loureiro JB, Inga A, Reis F, Gomes C, Santos MMM, Saraiva L. Soares J, et al. Among authors: ramos h. Mol Oncol. 2017 Jun;11(6):612-627. doi: 10.1002/1878-0261.12051. Epub 2017 May 2. Mol Oncol. 2017. PMID: 28296148 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

516 results

Search Page